Cyclophilin F Antibody (Rabbit mAb) [E22D20]

Catalog No.: F8662

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:4000
    1:100
    1:600
    Application
    WB, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    22 kDa 18 kDa, 23 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Cyclophilin F Antibody (Rabbit mAb) [E22D20] detects endogenous levels of total Cyclophilin F protein.
    Clone
    E22D20
    Synonym(s)
    CYP3, PPIF, PPIase F, Cyclophilin D, Cyclophilin F, Mitochondrial cyclophilin, Rotamase F, CyP-D, CypD, CyP-M
    Background
    Cyclophilin F, also known as peptidyl‑prolyl cis‑trans isomerase F (PPIF), is a mitochondrial member of the cyclophilin immunophilin family that catalyzes cis–trans isomerization of proline imidic peptide bonds and acts as a foldase and chaperone within the matrix, while also serving as a key regulator of mitochondrial permeability transition, ATP synthase function and cell death signaling. The protein adopts the conserved cyclophilin fold of eight antiparallel β‑strands forming a β‑barrel flanked by α‑helices, with a hydrophobic and positively charged active‑site pocket that binds proline‑containing substrates and the immunosuppressive drug cyclosporin A, and structural characterization of human mitochondrial cyclophilins demonstrates that substrate recognition and catalysis rely on conserved residues that stabilize the transition state and accelerate conformational rearrangements in client proteins. Cyclophilin F associates with components of the mitochondrial permeability transition pore (mPTP) at the inner membrane, and its interaction with pore elements modulates open probability in response to calcium, reactive oxygen species and inorganic phosphate; cyclosporin A binding to Cyclophilin F inhibits pore opening, decreases mitochondrial swelling and protects against necrotic and apoptotic stimuli, supporting a model in which Cyclophilin F acts as a modulatory factor whose PPIase‑dependent or ‑independent interactions with mPTP components govern threshold and kinetics of permeability transition. Beyond mPTP control, Cyclophilin F participates in the regulation of mitochondrial F1F0‑ATP synthase activity and matrix adenine nucleotide levels, influencing proton‑transporting ATPase function and coupling efficiency, and it has been reported to exert anti‑apoptotic effects independently of mPTP by cooperating with BCL2 to inhibit cytochrome c‑dependent apoptosis and negative regulation of intrinsic apoptotic signaling pathways, linking its chaperone and signaling roles directly to mitochondrial outer membrane permeabilization and caspase activation. Under oxidative stress, Cyclophilin F forms complexes with mitochondrial p53, and this cooperation promotes programmed necrotic cell death by enhancing mPTP opening and mitochondrial depolarization, illustrating that Cyclophilin F can participate in both survival and death pathways depending on its binding partners and post‑translational context. Human cyclophilins as a group are increasingly recognized as drug targets in cardiovascular disease, neurodegeneration, viral infection and cancer, and emerging reviews highlight that mitochondrial cyclophilins such as Cyclophilin F are involved in oxidative stress responses, ischemia–reperfusion injury and inflammatory signaling, making their active sites and cyclosporin‑binding surfaces attractive for small‑molecule modulation of mPTP and mitochondrial resilience.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください